Lentiviral interferon: A novel method for gene therapy in bladder cancer-Reference-Cited by-同舟云学术

Lentiviral interferon: A novel method for gene therapy in bladder cancer

Published:2022-09 Issue: Volume:26 Page:141-157
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Mokkapati Sharada^ORCID,Narayan Vikram M.,Manyam Ganiraju C.,Lim Amy H.,Duplisea Jonathan J.,Kokorovic Andrea,Miest Tanner S.,Mitra Anirban P.,Plote Devin,Anand Selvalakshmi Selvaraj,Metcalfe Michael J.,Dunner Kenneth,Johnson Burles A.,Czerniak Bogdan A.,Nieminen Tiina,Heikura Tommi,Yla-Herttuala Seppo,Parker Nigel R.,Schluns Kimberley S.,McConkey David J.,Dinney Colin P.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference45 articles.

1. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J. Urol.,2016

2. BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG;Kamat;Nat. Rev. Urol.,2017

3. Current clinical trials in non-muscle invasive bladder cancer;Siddiqui;Urol. Oncol.,2017

4. Human cancer gene therapy with cytokine gene-modified cells;Wysocki;Expert Opin. Biol. Ther.,2004

5. Clinical perspective: treatment of aggressive B cell lymphomas with FDA-approved CAR-T cell Therapies;Leick;Mol. Ther.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer;Expert Opinion on Biological Therapy;2024-06-02

2. Designing molecules: directing stem cell differentiation;Frontiers in Bioengineering and Biotechnology;2024-05-10

3. Challenges and Opportunities of Gene Therapy in Cancer;OBM Genetics;2024-03-04

4. Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval;Frontiers in Immunology;2023-08-29

5. The current status of gene therapy in bladder cancer;Expert Review of Anticancer Therapy;2023-04-25